Supplemental Table 1: Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions; a retrospective cohort study
Published: 13 November 2023| Version 1 | DOI: 10.17632/hhwsdm8vsh.1
Contributors:
Emily Granger, Emily Ruiz, Emily Karn, Morgan GrooverDescription
The association of systemic medication exposure with mean tumor accrual rate in immunosuppressed patients relative to immunocompetent controls
Files
Steps to reproduce
Retrospective cohort study; medical record chart review; analysis with STATA, version 17 (StataCorp)
Institutions
Brigham and Women's Hospital, Harvard Medical School
Categories
Oncology, Autoimmune Disorder, Immunosuppression, Squamous Cell Carcinoma, Inflammatory Disorder